RT Journal Article
SR Electronic
T1 Measles Burden Estimation Using Local Gaussian Process Classifiers
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.05.17.22275226
DO 10.1101/2022.05.17.22275226
A1 Li, Xiaoxiao
A1 Lan, Zhou
A1 Ferrari, Matthew
A1 Haran, Murali
YR 2022
UL http://medrxiv.org/content/early/2022/05/21/2022.05.17.22275226.abstract
AB Measles is a highly contagious viral disease and remains a severe public health problem. Monitoring measles cases provides a powerful tool to identify outbreaks and epidemics. However, burden estimates of measles are challenging to obtain because of heterogeneous surveillance systems and a lack of resources for rapid laboratory tests means that many cases are reported based on symptoms alone, which has low specificity. We consider diagnostically confirmed measles case data in Ethiopia between 2009 and 2017 and propose a local Gaussian process binary classifier with spatial dependence to provide case predictions for untested individuals based on age, vaccination status, and location. By applying our modeling framework to untested suspected reported cases, we provide more accurate burden estimates at the district level. We validate our methods through simulation studies. We also find that our approach, which provides burden estimates at the district level, highlights temporal variation in the specificity of symptom-based diagnosis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors acknowledge support from the National Science Foundation (NSF) Ecology and Evolution of Infectious Diseases (EEID) program award Division of Environmental Biology (DEB) 1911962; Biotechnology and Biological Sciences Research Council (BBSRC) BB/T004312/1, and the Bill and Melinda Gates Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Penn State University, Office for Research Protections determined that the proposed activity, as described in the above-referenced submission, does not require formal IRB review because the research met the criteria for exempt research according to the policies of this institution and the provisions of applicable federal regulations.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThese data are the property of the government of Ethiopia and the WHO. Access to these data can be requested directly from WHO Division of Immunization, Vaccinations, and Biologicals. To illustrate the application of the methods described herein, we have provided the readers with a simulated data set used in our manuscript. These data have similar characteristics to the real data: https://github.com/lxxiww/Measles-Surveillance https://github.com/lxxiww/Measles-Surveillance